Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: In vitro destruction of cells bearing substance Preceptors

被引:18
作者
Fisher, CE
Sutherland, JA
Krause, JE
Murphy, JR
Leeman, SE
vanderSpek, JC
机构
[1] BOSTON UNIV,MED CTR HOSP,EVANS DEPT CLIN RES,SECT BIOMOL MED,BOSTON,MA 02118
[2] BOSTON UNIV,MED CTR HOSP,DEPT MED,BOSTON,MA 02118
[3] BOSTON UNIV,SCH MED,DEPT PHARMACOL,BOSTON,MA 02118
[4] WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110
关键词
D O I
10.1073/pnas.93.14.7341
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have genetically replaced the native receptor binding domain of diphtheria toxin with an extended form of substance P (SP): SP-glycine (SP-Gly). The resulting fusion protein, DAB(389)SP-Gly, is composed of the catalytic and transmembrane domains of diphtheria toxin genetically coupled to SP-Gly. Because native SP requires a C-terminal amide moiety to bind with high affinity to the SP receptor, the precursor form of the fusion toxin, DAB(389)SP-Gly, was converted to DAB(389)SP by treatment with peptidylglycine-alpha-amidating monooxygenase. We demonstrate that following conversion, DAB(389)SP is selectively cytotoxic for cell lines that express either the rat or the human SP receptor. We also demonstrate that the cytotoxic action of DAB(389)SP is mediated via the SP receptor and dependent upon passage through an acidic compartment. To our knowledge, this is the first reported use of a neuropeptide as the targeting ligand for a fusion toxin; and the first instance in which an inactive precursor form of a fusion toxin is converted to the active form by a posttranslational modification.
引用
收藏
页码:7341 / 7345
页数:5
相关论文
共 18 条
[1]   DIRECT OBSERVATION OF SUBSTANCE-P-INDUCED INTERNALIZATION OF NEUROKININ-1 (NK1) RECEPTORS AT SITES OF INFLAMMATION [J].
BOWDEN, JJ ;
GARLAND, AM ;
BALUK, P ;
LEFEVRE, P ;
GRADY, EF ;
VIGNA, SR ;
BUNNETT, NW ;
MCDONALD, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8964-8968
[2]  
CHANG MM, 1970, J BIOL CHEM, V245, P4784
[3]   AMINO-ACID SEQUENCE OF SUBSTANCE P [J].
CHANG, MM ;
LEEMAN, SE ;
NIALL, HD .
NATURE-NEW BIOLOGY, 1971, 232 (29) :86-+
[4]   THE BIOSYNTHESIS OF NEUROPEPTIDES - PEPTIDE ALPHA-AMIDATION [J].
EIPPER, BA ;
STOFFERS, DA ;
MAINS, RE .
ANNUAL REVIEW OF NEUROSCIENCE, 1992, 15 :57-85
[5]  
EIPPER BA, 1993, PROTEIN SCI, V2, P489
[6]   AGONIST-INDUCED INTERNALIZATION OF THE SUBSTANCE-P (NK1) RECEPTOR EXPRESSED IN EPITHELIAL-CELLS [J].
GARLAND, AM ;
GRADY, EF ;
PAYAN, DG ;
VIGNA, SR ;
BUNNETT, NW .
BIOCHEMICAL JOURNAL, 1994, 303 :177-186
[7]   SUBSTANCE-P RECEPTORS IN HUMAN PRIMARY NEOPLASMS - TUMORAL AND VASCULAR LOCALIZATION [J].
HENNIG, IM ;
LAISSUE, JA ;
HORISBERGER, U ;
REUBI, JC .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (06) :786-792
[8]  
INGI T, 1991, J PHARMACOL EXP THER, V259, P968
[9]  
MANTYH PW, 1989, J NEUROSCI, V9, P258
[10]   C-TERMINAL AMIDATED PEPTIDES - PRODUCTION BY THE IN-VITRO ENZYMATIC AMIDATION OF GLYCINE-EXTENDED PEPTIDES AND THE IMPORTANCE OF THE AMIDE TO BIOACTIVITY [J].
MERKLER, DJ .
ENZYME AND MICROBIAL TECHNOLOGY, 1994, 16 (06) :450-456